Codexis to Sell Pompe, Fabry Assets to Crosswalk Therapeutics

Seeking Alpha05:28

6-K: Report of foreign private issuer (related to financial reporting)

SEC announcementJul 1 18:39 · Announcements

20-F: Registration statement / Annual report / Transition report

SEC announcementJun 26 18:13 · Announcements

6-K: Notice of Resolutions at the 148th Ordinary General Meeting of Shareholders

SEC announcementJun 26 18:04 · Announcements

Takeda Announces the Publication of Its Annual Report on Form 20-F for FY2023

OSAKA, Japan, June 26, 2024 – Takeda (TSE:4502/NYSE:TAK) today announced that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2024 (the "Annual Report") with the U.S. S

Takeda PharmaceuticalJun 26 12:00

Wave Jumps on Trial Data for Huntington's Disease Therapy

Seeking AlphaJun 25 20:13